Education
About Us
Working with TipRanks
Follow Us
John Kiely Insider Profile
4 Followers
John Kiely, Director at Amneal Pharmaceuticals, holds 257.43K shares in Amneal Pharmaceuticals (Ticker: AMRX), holds 71.86K shares in Zovio (Ticker: ZVOI). Most recently, John Kiely Sold ― shares of Amneal Pharmaceuticals on May 13, 2025 for an estimated value of 379.50K.
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-3.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 19, 2020 - May 19, 2021
Return:+27.10%
The most profitable trade made by John Kiely
John Kiely's Trading History
Amneal Pharmaceuticals
May 13, 2025
Director
Informative Sell
379.50K
$2.02M
Zovio
Sep 02, 2022
Director
Uninformative Buy
2.32K
$14.37K
List of latest transactions for each holding click on a transaction to see John Kiely's performance on stock
You May Also Like
John Kiely insider profile FAQ
What is the percentage of profitable transactions made by John Kiely?
The percentage of profitable transactions made by John Kiely is 50%.
What is the average return per transaction made by John Kiely?
The average return per transaction made by John Kiely is -3.20%.
What stocks does John Kiely hold?
John Kiely holds: AMRX, ZVOI stocks.
What was John Kiely’s latest transaction?
John Kiely latest transaction was an Informative Sell of $379.50K.
What was John Kiely's most profitable transaction?
John Kiely’s most profitable transaction was an Informative Buy of AMRX stock on May 19, 2020. The return on the trade was 27.10%.
What is John Kiely's role in Amneal Pharmaceuticals?
John Kiely's role in Amneal Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.